Yahoo Web Search

Search results

  1. Previously, he served as President, Healthcare at GoodRx, Inc., in addition to Executive Vice President and Chief Strategy and Business Development Officer at McKesson Corporation. Mr. Nagji also has extensive background as a board member for both private and public companies, including Change Healthcare, Deloitte, and Parata Systems.

  2. Jul 25, 2024 · Mr. Nagji said, "PANTHERx Rare has achieved significant scale and impact under Rob's leadership since 2011, and I am thrilled to move into the role of CEO to lead the Company through its next ...

  3. Prior to that, Mr. Nagji was with Monitor Group, a global strategy consulting firm, for twenty years where he was a senior partner and president when the firm merged with Deloitte. Mr. Nagji served previously on the board of Change Healthcare until March 2020, and on the board of directors of Deloitte, LLP from 2013 to 2015.

    • Director
    • Change Healthcare, Change Healthcare
  4. Jan 8, 2024 · Mr. Nagji brings to the role more than 25 years of leadership experience in pharma services and supply chain [logistics / operations], healthcare technology, and digital platforms. His operating ...

  5. Jun 18, 2020 · Mr. Nagji received his B.A. and M.A. from Cambridge University and an M.B.A. with Distinction from INSEAD. About Change Healthcare. Change Healthcare (Nasdaq: CHNG) is a leading independent ...

  6. Jun 15, 2020 · Mr. Nagji has been recognized multiple times by EMpower as a senior executive role model for minorities in the workplace. He is also an active supporter of several not-for-profit organizations.

  7. People also ask

  8. Bansi brings to the CEO role more than 25 years of leadership experience spanning pharma services and supply chain, healthcare technology, and digital platforms. He has deep operating and strategic experience leading high-growth businesses and developing and executing organic and inorganic growth strategies. Mr. Nagji had previously served as ...

  1. People also search for